Tight junctions and the regulation of gene expression

Seminars in Cell and Developmental Biology

Volumn 36, Issue , 2014, Pages 213-223

  González Mariscal, Lorenza ^a   Domínguez Calderón, Alaide ^a   Raya Sandino, Arturo ^a   Ortega Olvera, José Mario ^a   Vargas Sierra, Orlando ^a   Martínez Revollar, Gabriela ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Cingulin; Claudins; Gene expression; Tight junctions; ZO

Indexed keywords

CINGULIN; CLAUDIN; CLAUDIN 1; CLAUDIN 18; CLAUDIN 6; CLAUDIN 7; CLAUDIN 8; JUNCTIONAL ADHESION MOLECULE A; MAGI 1 PROTEIN; MARVELD3 PROTEIN; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; METALLOPROTEINASE; OCCLUDIN; PARACINGULIN; PROTEIN ZO1; PROTEIN ZO2; RNA POLYMERASE II; SYMPLEKIN; TIGHT JUNCTION PROTEIN; UBINUCLEIN; UNCLASSIFIED DRUG;

CELL NUCLEUS; CELLULAR DISTRIBUTION; GENE CONTROL; GENE EXPRESSION; NONHUMAN; PROTEIN LOCALIZATION; REVIEW; TIGHT JUNCTION; TRANSCRIPTION REGULATION;

EID: 85027920932     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.08.009     Document Type: Review

References (88)

1. Farquhar M.G., Palade G.E. Junctional complexes in various epithelia. J Cell Biol 1963, 17:375-412.
2. Gonzalez-Mariscal L., Betanzos A., Nava P., Jaramillo B.E. Tight junction proteins. Prog Biophys Mol Biol 2003, 81(1):1-44.
3. Lopez-Bayghen E., Jaramillo B.E., Huerta M., Betanzos A., Gonzalez-Marical L. TJ proteins that make round trips to the nucleus. Tight junctions 2006, 76-100. Landes Bioscience/Springer Science/Business Media, Georgetown, TX/New York, NY. L. Gonzalez-Mariscal (Ed.).
4. Gottardi C.J., Arpin M., Fanning A.S., Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci U S A 1996, 93(20):10779-10784.
5. Balda M.S., Garrett M.D., Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 2003, 160(3):423-432.
6. Balda M.S., Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 2000, 19(9):2024-2033.
7. Frankel P., Aronheim A., Kavanagh E., Balda M.S., Matter K., Bunney T.D., et al. RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J 2005, 24(1):54-62.
8. Sourisseau T., Georgiadis A., Tsapara A., Ali R.R., Pestell R., Matter K., et al. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol 2006, 26(6):2387-2398.
9. Nie M., Aijaz S., Leefa Chong San I.V., Balda M.S., Matter K. The Y-box factor ZONAB/DbpA associates with GEF-H1/Lfc and mediates Rho-stimulated transcription. EMBO Rep 2009, 10(10):1125-1131.
10. Tsapara A., Matter K., Balda M.S. The heat-shock protein Apg-2 binds to the tight junction protein ZO-1 and regulates transcriptional activity of ZONAB. Mol Biol Cell 2006, 17(3):1322-1330.
11. Nie M., Balda M.S., Matter K. Stress- and Rho-activated ZO-1-associated nucleic acid binding protein binding to p21 mRNA mediates stabilization, translation, and cell survival. Proc Natl Acad Sci U S A 2012, 109(27):10897-10902.
12. Lima W.R., Parreira K.S., Devuyst O., Caplanusi A., N'Kuli F., Marien B., et al. ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells. J Am Soc Nephrol 2010, 21(3):478-488.
13. Georgiadis A., Tschernutter M., Bainbridge J.W., Balaggan K.S., Mowat F., West E.L., et al. The tight junction associated signalling proteins ZO-1 and ZONAB regulate retinal pigment epithelium homeostasis in mice. PLoS ONE 2010, 5(12):pe15730.
14. Gonzalez-Mariscal L., Ponce A., Alarcon L., Jaramillo B.E. The tight junction protein ZO-2 has several functional nuclear export signals. Exp Cell Res 2006, 312(17):3323-3335.
15. Quiros M., Alarcon L., Ponce A., Giannakouros T., Gonzalez-Mariscal L. The intracellular fate of zonula occludens 2 is regulated by the phosphorylation of SR repeats and the phosphorylation/O-GlcNAcylation of S257. Mol Biol Cell 2013, 24(16):2528-2543.
16. Chamorro D., Alarcon L., Ponce A., Tapia R., Gonzalez-Aguilar H., Robles-Flores M., et al. Phosphorylation of zona occludens-2 by protein kinase C epsilon regulates its nuclear exportation. Mol Biol Cell 2009, 20(18):4120-4129.
17. Tapia R., Huerta M., Islas S., Avila-Flores A., Lopez-Bayghen E., Weiske J., et al. Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle. Mol Biol Cell 2009, 20(3):1102-1117.
18. Islas S., Vega J., Ponce L., Gonzalez-Mariscal L. Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res 2002, 274(1):138-148.
19. Lechuga S., Alarcon L., Solano J., Huerta M., Lopez-Bayghen E., Gonzalez-Mariscal L. Identification of ZASP, a novel protein associated to Zona occludens-2. Exp Cell Res 2010, 316(19):3124-3139.
20. Traweger A., Fuchs R., Krizbai I.A., Weiger T.M., Bauer H.C., Bauer H. The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B. J Biol Chem 2003, 278(4):2692-2700.
21. Meerschaert K., Tun M.P., Remue E., De Ganck A., Boucherie C., Vanloo B., et al. The PDZ2 domain of zonula occludens-1 and -2 is a phosphoinositide binding domain. Cell Mol Life Sci 2009, 66(24):3951-3966.
22. Li H., Bingham P.M. Arginine/serine-rich domains of the su(wa) and tra RNA processing regulators target proteins to a subnuclear compartment implicated in splicing. Cell 1991, 67(2):335-342.
23. Jaramillo B.E., Ponce A., Moreno J., Betanzos A., Huerta M., Lopez-Bayghen E., et al. Characterization of the tight junction protein ZO-2 localized at the nucleus of epithelial cells. Exp Cell Res 2004, 297(1):247-258.
24. Betanzos A., Huerta M., Lopez-Bayghen E., Azuara E., Amerena J., Gonzalez-Mariscal L. The tight junction protein ZO-2 associates with Jun Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res 2004, 292(1):51-66.
25. Huerta M., Munoz R., Tapia R., Soto-Reyes E., Ramirez L., Recillas-Targa F., et al. Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc. Mol Biol Cell 2007, 18(12):4826-4836.
26. Huang H.Y., Li R., Sun Q., Wang J., Zhou P., Han H., et al. LIM protein KyoT2 interacts with human tight junction protein ZO-2-i3. Yi Chuan Xue Bao 2002, 29(11):953-958.
27. Bautista-Garcia P., Reyes J.L., Martin D., Namorado M.C., Chavez-Munguia B., Soria-Castro E., et al. Zona occludens-2 protects against podocyte dysfunction induced by ADR in mice. Am J Physiol Renal Physiol 2013, 304(1):F77-F87.
28. Traweger A., Lehner C., Farkas A., Krizbai I.A., Tempfer H., Klement E., et al. Nuclear Zonula occludens-2 alters gene expression and junctional stability in epithelial and endothelial cells. Differentiation 2008, 76(1):99-106.
29. Mazurek S., Boschek C.B., Hugo F., Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 2005, 15(4):300-308.
30. Chlenski A., Ketels K.V., Engeriser J.L., Talamonti M.S., Tsao M.S., Koutnikova H., et al. zo-2 gene alternative promoters in normal and neoplastic human pancreatic duct cells. Int J Cancer 1999, 83(3):349-358.
31. Chlenski A., Ketels K.V., Tsao M.S., Talamonti M.S., Anderson M.R., Oyasu R., et al. Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma. Int J Cancer 1999, 82(1):137-144.
32. Luczka E., Syne L., Nawrocki-Raby B., Kileztky C., Hunziker W., Birembaut P., et al. Regulation of membrane-type 1 matrix metalloproteinase expression by zonula occludens-2 in human lung cancer cells. Clin Exp Metastasis 2013, 30(7):833-843.
33. Oka T., Sudol M. Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif. Genes Cells 2009, 14(5):607-615.
34. Oka T., Remue E., Meerschaert K., Vanloo B., Boucherie C., Gfeller D., et al. Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem J 2010, 432(3):461-472.
35. Glaunsinger B.A., Lee S.S., Thomas M., Banks L., Javier R. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 2000, 19(46):5270-5280.
36. Thomas M., Kranjec C., Nagasaka K., Matlashewski G., Banks L. Analysis of the PDZ binding specificities of Influenza A virus NS1 proteins. Virol J 2011, 8:p25.
37. Kumar M., Liu H., Rice A.P. Regulation of interferon-beta by MAGI-1 and its interaction with influenza A virus NS1 protein with ESEV PBM. PLOS ONE 2012, 7(7):pe41251.
38. Aho S., Buisson M., Pajunen T., Ryoo Y.W., Giot J.F., Gruffat H., et al. Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factors. J Cell Biol 2000, 148(6):1165-1176.
39. Lupo J., Conti A., Sueur C., Coly P.A., Coute Y., Hunziker W., et al. Identification of new interacting partners of the shuttling protein ubinuclein (Ubn-1). Exp Cell Res 2012, 318(5):509-520.
40. Aho S., Lupo J., Coly P.A., Sabine A., Castellazzi M., Morand P., et al. Characterization of the ubinuclein protein as a new member of the nuclear and adhesion complex components (NACos). Biol Cell 2009, 101(6):319-334.
41. Tang Y., Puri A., Ricketts M.D., Rai T.S., Hoffmann J., Hoi E., et al. Identification of an ubinuclein 1 region required for stability and function of the human HIRA/UBN1/CABIN1/ASF1a histone H3.3 chaperone complex. Biochemistry 2012, 51(12):2366-2377.
42. Keon B.H., Schafer S., Kuhn C., Grund C., Franke W.W. Symplekin, a novel type of tight junction plaque protein. J Cell Biol 1996, 134(4):1003-1018.
43. Kavanagh E., Buchert M., Tsapara A., Choquet A., Balda M.S., Hollande F., et al. Functional interaction between the ZO-1-interacting transcription factor ZONAB/DbpA and the RNA processing factor symplekin. J Cell Sci 2006, 119(Pt 24):5098-5105.
44. Buchert M., Darido C., Lagerqvist E., Sedello A., Cazevieille C., Buchholz F., et al. The symplekin/ZONAB complex inhibits intestinal cell differentiation by the repression of AML1/Runx1. Gastroenterology 2009, 137(1):156-164. 164 e1-3.
45. Buchert M., Papin M., Bonnans C., Darido C., Raye W.S., Garambois V., et al. Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proc Natl Acad Sci U S A 2010, 107(6):2628-2633.
46. Largeot A., Paggetti J., Broseus J., Aucagne R., Lagrange B., Martin R.Z., et al. Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells. Biochim Biophys Acta 2013, 1833(12):3054-3063.
47. Cordenonsi M., D'Atri F., Hammar E., Parry D.A., Kendrick-Jones J., Shore D., et al. Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2 ZO-3, and myosin. J Cell Biol 1999, 147(7):1569-1582.
48. Ohnishi H., Nakahara T., Furuse K., Sasaki H., Tsukita S., Furuse M. JACOP, a novel plaque protein localizing at the apical junctional complex with sequence similarity to cingulin. J Biol Chem 2004, 279(44):46014-46022.
49. Yano T., Matsui T., Tamura A., Uji M., Tsukita S. The association of microtubules with tight junctions is promoted by cingulin phosphorylation by AMPK. J Cell Biol 2013, 203(4):605-614.
50. Pulimeno P., Paschoud S., Citi S. A role for ZO-1 and PLEKHA7 in recruiting paracingulin to tight and adherens junctions of epithelial cells. J Biol Chem 2011, 286(19):16743-16750.
51. Terry S.J., Zihni C., Elbediwy A., Vitiello E., Leefa Chong San I.V., Balda M.S., et al. Spatially restricted activation of RhoA signalling at epithelial junctions by p114RhoGEF drives junction formation and morphogenesis. Nat Cell Biol 2011, 13(2):159-166.
52. Samarin S.N., Ivanov A.I., Flatau G., Parkos C.A., Nusrat A. Rho/Rho-associated kinase-II signaling mediates disassembly of epithelial apical junctions. Mol Biol Cell 2007, 18(9):3429-3439.
53. Aijaz S., D'Atri F., Citi S., Balda M.S., Matter K. Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition. Dev Cell 2005, 8(5):777-786.
54. Guillemot L., Paschoud S., Jond L., Foglia A., Citi S. Paracingulin regulates the activity of Rac1 and RhoA GTPases by recruiting Tiam1 and GEF-H1 to epithelial junctions. Mol Biol Cell 2008, 19(10):4442-4453.
55. Guillemot L., Hammar E., Kaister C., Ritz J., Caille D., Jond L., et al. Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci 2004, 117(Pt 22):5245-5256.
56. Guillemot L., Schneider Y., Brun P., Castagliuolo I., Pizzuti D., Martines D., et al. Cingulin is dispensable for epithelial barrier function and tight junction structure, and plays a role in the control of claudin-2 expression and response to duodenal mucosa injury. J Cell Sci 2012, 125(Pt 21):5005-5014.
57. Guillemot L., Citi S. Cingulin regulates claudin-2 expression and cell proliferation through the small GTPase RhoA. Mol Biol Cell 2006, 17(8):3569-3577.
58. Citi S., Cordenonsi M. The molecular basis for the structure, function and regulation of tight junctions. Adhesive interactions of cells 1999, 203-233. JAI Press Inc., Greenwich. A.J. North, D.R. Garrod, M.A.J. Chidgey (Eds.).
59. Nakamura T., Blechman J., Tada S., Rozovskaia T., Itoyama T., Bullrich F., et al. huASH1 protein, a putative transcription factor encoded by a human homologue of the Drosophila ash1 gene, localizes to both nuclei and cell-cell tight junctions. Proc Natl Acad Sci U S A 2000, 97(13):7284-7289.
60. Guillemot L., Spadaro D., Citi S. The junctional proteins cingulin and paracingulin modulate the expression of tight junction protein genes through GATA-4. PLOS ONE 2013, 8(2):pe55873.
61. Citi S., Paschoud S., Pulimeno P., Timolati F., De Robertis F., Jond L., et al. The tight junction protein cingulin regulates gene expression and RhoA signaling. Ann N Y Acad Sci 2009, 1165:88-98.
62. Gunzel D., Yu A.S. Claudins and the modulation of tight junction permeability. Physiol Rev 2013, 93(2):525-569.
63. Gonzalez-Mariscal L., Diaz Coranguez M., Quiros M. Regulation of tight junctions for therapeutic advantages. Tight junctions in cancer metastasis 2013, Springer, Netherlands. T.A. Martin, W.G. Jiang (Eds.).
64. Sanchez-Pulido L., Martin-Belmonte F., Valencia A., Alonso M.A. MARVEL: a conserved domain involved in membrane apposition events. Trends Biochem Sci 2002, 27(12):599-601.
65. McCarthy K.M., Skare I.B., Stankewich M.C., Furuse M., Tsukita S., Rogers R.A., et al. Occludin is a functional component of the tight junction. J Cell Sci 1996, 109(Pt 9):2287-2298.
66. Balda M.S., Whitney J.A., Flores C., Gonzalez S., Cereijido M., Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 1996, 134(4):1031-1049.
67. Lacaz-Vieira F., Jaeger M.M., Farshori P., Kachar B. Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing. J Membr Biol 1999, 168(3):289-297.
68. Feng S., Cen J., Huang Y., Shen H., Yao L., Wang Y., et al. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS ONE 2011, 6(8):pe20599.
69. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000, 11(12):4131-4142.
70. Osanai M., Murata M., Nishikiori N., Chiba H., Kojima T., Sawada N. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res 2006, 66(18):9125-9133.
71. Vietor I., Bader T., Paiha K., Huber L.A. Perturbation of the tight junction permeability barrier by occludin loop peptides activates beta-catenin/TCF/LEF-mediated transcription. EMBO Rep 2001, 2(4):306-312.
72. Osanai M., Murata M., Nishikiori N., Chiba H., Kojima T., Sawada N. Occludin-mediated premature senescence is a fail-safe mechanism against tumorigenesis in breast carcinoma cells. Cancer Sci 2007, 98(7):1027-1034.
73. Steed E., Rodrigues N.T., Balda M.S., Matter K. Identification of MarvelD3 as a tight junction-associated transmembrane protein of the occludin family. BMC Cell Biol 2009, 10:95.
74. Steed E., Elbediwy A., Vacca B., Dupasquier S., Hemkemeyer S.A., Suddason T., et al. MarvelD3 couples tight junctions to the MEKK1-JNK pathway to regulate cell behavior and survival. J Cell Biol 2014, 204(5):821-838.
75. Itoh M., Sasaki H., Furuse M., Ozaki H., Kita T., Tsukita S. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol 2001, 154(3):491-497.
76. Eckert J.J., Fleming T.P. Tight junction biogenesis during early development. Biochim Biophys Acta 2008, 1778(3):717-728.
77. Laukoetter M.G., Nava P., Lee W.Y., Severson E.A., Capaldo C.T., Babbin B.A., et al. JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med 2007, 204(13):3067-3076.
78. Singh A.B., Sharma A., Smith J.J., Krishnan M., Chen X., Eschrich S., et al. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. Gastroenterology 2011, 141(6):2140-2153.
79. Inai T., Kobayashi J., Shibata Y. Claudin-1 contributes to the epithelial barrier function in MDCK cells. Eur J Cell Biol 1999, 78(12):849-855.
80. Ikari A., Sato T., Takiguchi A., Atomi K., Yamazaki Y., Sugatani J. Claudin-2 knockdown decreases matrix metalloproteinase-9 activity and cell migration via suppression of nuclear Sp1 in A549 cells. Life Sci 2011, 88(13-14):628-633.
81. Ikari A., Takiguchi A., Atomi K., Sato T., Sugatani J. Decrease in claudin-2 expression enhances cell migration in renal epithelial Madin-Darby canine kidney cells. J Cell Physiol 2011, 226(6):1471-1478.
82. Nishida M., Yoshida M., Nishiumi S., Furuse M., Azuma T. Claudin-2 regulates colorectal inflammation via myosin light chain kinase-dependent signaling. Dig Dis Sci 2013, 58(6):1546-1559.
83. Ren Y., Wu Q., Liu Y., Xu X., Quan C. Gene silencing of claudin6 enhances cell proliferation and migration accompanied with increased MMP2 activity via p38 MAPK signaling pathway in human breast epithelium cell line HBL100. Mol Med Rep 2013, 8(5):1505-1510.
84. Ding L., Lu Z., Foreman O., Tatum R., Lu Q., Renegar R., et al. Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice. Gastroenterology 2012, 142(2):305-315.
85. Lioni M., Brafford P., Andl C., Rustgi A., El-Deiry W., Herlyn M., et al. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 2007, 170(2):709-721.
86. Yu A.S., Enck A.H., Lencer W.I., Schneeberger E.E. Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem 2003, 278(19):17350-17359.
87. Ip Y.C., Cheung S.T., Lee Y.T., Ho J.C., Fan S.T. Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells. Mol Cancer Ther 2007, 6(11):2858-2867.
88. Li G., Flodby P., Luo J., Kage H., Sipos A., Gao D., et al. Knockout mice reveal key roles for claudin 18 in alveolar barrier properties and fluid homeostasis. Am J Respir Cell Mol Biol 2014, 51:210-222.